Clinical trial
Immunogenicity of a Single Dose of MenB-FHbp or MenACWY-TT/MenB-FHbp in MenB-4C Primed Young Adults
NCT07197762 is registered in ClinicalTrials.gov with Emory University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Immunogenicity of a Single Dose of MenB-FHbp or MenACWY-TT/MenB-FHbp in MenB-4C Primed Young Adults
- Lead sponsor
- Emory University
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- November 4, 2025
- Completion date
- December 31, 2026
- Enrollment
- 125 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
neisseria meningitidis